Workflow
Frontier Telecom's Hidden Gem: VEON's Undervalued Growth And Nasdaq Catalyst
Seeking Alpha· 2025-06-13 09:39
VEON Ltd. (NASDAQ: VEON ) is a leading global digital operator, combining traditional telecommunication services, fast-growing fintech and streaming services across 5 key high growth frontier markets. Its market cap is only $3.3bn, and it is significantly lower than its peers like Bharti Airtel of $130bnI am currently working as an investment analyst at a family office. My specialty is identifying high-quality and/or severely mispriced investment ideas. I believe that a great investment idea would "jump" at ...
Pinnacle West Vs. Avista: A Classic Tradeoff For Investors
Seeking Alpha· 2025-06-13 09:38
Pinnacle West (NYSE: PNW ) and Avista Corporation (NYSE: AVA ) are close peers in that they’re both regulated electric utilities operating in the Western U.S., but they have rather different investment profiles. Arizona-based PNW has growthJoseph Jones, professor at The University of Southern Mississippi, has over fifteen years of experience studying the market. He focuses on portfolio construction from a dividend growth investor's perspective. The insights expressed in his research are solely his own; they ...
Better Quantum Computing Stock: Rigetti Computing or IonQ?
The Motley Fool· 2025-06-13 09:30
Quantum computing stocks are still quite hot in the market, although their week-to-week performance can be incredibly volatile. For example, one of the more popular quantum computing plays, Rigetti Computing (RGTI -3.12%), set a new all-time high right at the end of 2024, but plunged 70% just a few weeks into 2025. Now, it's only off around 40% from its all-time high. One of its peers, IonQ (IONQ -2.28%), has also seen extreme volatility, although not quite the same level as Rigetti.Of these two, is one a m ...
Meridian Corporation: Still A Buy Despite A Downward Revision Of Earnings
Seeking Alpha· 2025-06-13 09:18
Group 1 - The company is reducing its mortgage banking income estimate due to a weak housing market [1] - The expected EPS for the company in 2025 has been revised down to $1.43 from a previous estimate of $1.67 [1]
Up 17% in 2025, Is It Time to Buy This Soaring Growth Stock and Hold for the Long Term?
The Motley Fool· 2025-06-13 09:18
One of the most popular investment strategies rests on finding businesses that can quickly increase their revenue and earnings. By putting money into these opportunities, investors are hoping they can generate strong portfolio returns.There's one growth stock up 17% in 2025 (as of June 10). That performance trounces the 2% gain of the S&P 500 index (^GSPC 0.38%). But investors might not be familiar with this business, given that it carries a market cap of just $6.8 billion.Maybe now is a good time to take a ...
Netcompany - Major shareholder announcement
Globenewswire· 2025-06-13 09:17
Group 1 - Danske Bank A/S has notified Netcompany Group A/S regarding their direct and indirect holdings and voting rights in the company [1][2] - As of June 11, 2025, Danske Bank A/S controls 2,587,150 voting rights, which corresponds to 5.45% of the total voting rights in Netcompany [2]
RetinalGenix Technologies Welcomes Dr. Taimour Langaee as Advisor for DNA GPS Pharmacogenetics Initiatives
Globenewswire· 2025-06-13 09:15
Core Insights - RetinalGenix Technologies Inc. has appointed Dr. Taimour Langaee as a scientific advisor to enhance its DNA GPS Pharmacogenetics initiatives aimed at optimizing personalized treatment pathways for retinal and systemic diseases [1][5] - Dr. Langaee brings over 20 years of experience in pharmacogenomics and precision medicine, overseeing genotyping, sequencing data processing, and clinical genetic association studies [2][3] - The company aims to integrate advanced retinal imaging with pharmacogenetics and AI to identify early signs of chronic diseases, thereby improving overall health management and reducing long-term healthcare costs [6][7] Company Overview - RetinalGenix is focused on revolutionizing early disease detection and improving patient outcomes by combining genetic screening, advanced imaging, and therapeutic development [9] - The company's proprietary technologies include High-Resolution Retinal Imaging and DNA/RNA/GPS Pharmaco-Genetic Mapping™, which are designed to prevent blindness and detect physiological changes indicating future ocular and systemic diseases [9] Strategic Goals - The integration of Dr. Langaee's expertise is expected to accelerate the company's efforts in delivering personalized, data-driven solutions for retinal and systemic health [5] - RetinalGenix's approach includes remote monitoring and personalized risk assessments based on genetic profiles, which aims to maximize the effectiveness of preventive strategies [7][8]
Top Wall Street Forecasters Revamp Digital Turbine Expectations Ahead Of Q4 Earnings
Benzinga· 2025-06-13 09:08
Core Insights - Digital Turbine, Inc. is expected to report a quarterly earnings decline to 4 cents per share, down from 12 cents per share in the same period last year [1] - The company projects quarterly revenue of $116.64 million, an increase from $112.22 million a year earlier [1] Recent Performance - On February 5, Digital Turbine reported quarterly earnings of 13 cents per share, exceeding the analyst consensus estimate of a loss of 1 cent [2] - Quarterly revenue was reported at $134.64 million, surpassing the consensus estimate of $123.68 million [2] - Following the earnings report, Digital Turbine shares fell by 4.1% to close at $4.98 [2] Analyst Ratings - B of A Securities analyst downgraded the stock from Neutral to Underperform, reducing the price target from $3.5 to $1 [6] - Macquarie analyst maintained a Neutral rating and lowered the price target from $3 to $2 [6] - Craig-Hallum analyst maintained a Buy rating but cut the price target from $5 to $4 [6]
While Tesla Talks, Waymo Drives
Forbes· 2025-06-13 09:05
Core Insights - Tesla has established itself as a leader in autonomous driving with its Full Self-Driving (FSD) software, which automates certain driving tasks but still requires driver supervision [2] - Despite high expectations, FSD does not significantly contribute to Tesla's revenues, especially as competition in the EV market increases [2] - The subscription model for FSD is gaining traction, with estimates suggesting that around 10% of new Tesla buyers may opt for it, potentially generating approximately $550 million in annual revenue [3][4] FSD Revenue and Market Position - Tesla offers FSD for a one-time fee of $8,000 or a subscription at $99 per month, with the subscription likely being the preferred choice for new buyers [3] - By the end of 2025, cumulative FSD subscriptions could reach around 460,000, translating to an estimated $550 million in annual revenue, which is a small fraction of Tesla's total sales [4] - The valuation premium of Tesla's stock is not fully justified by the current FSD revenue, indicating a potential disconnect between market expectations and actual performance [4] Competitive Landscape - Elon Musk has made ambitious claims about FSD advancements, but the actual improvements have fallen short, with the latest version showing only a 2.5 times increase in miles driven between disengagements [5] - In contrast, Waymo has made significant progress, conducting over 250,000 fully autonomous rides weekly, showcasing a more advanced level of autonomy compared to Tesla's FSD [6][7] - Waymo's vehicles operate without human oversight and have demonstrated a 78% reduction in injury-causing crashes compared to human drivers, highlighting its competitive edge in safety and user preference [7] Tesla's Potential Advantages - Tesla's reliance on a camera-only system powered by neural networks may offer a simpler and more cost-effective approach to scaling its FSD technology compared to Waymo's complex hardware requirements [8] - With over 5 million Teslas on the road, a significant portion may be equipped to run FSD software, providing a large potential user base for future advancements [8]
Warren Buffett and Cathie Wood Only Own 1 Stock in Common, and Billionaire Investor Bill Ackman Just Bought It, Too
The Motley Fool· 2025-06-13 09:05
Warren Buffett, Cathie Wood, and Bill Ackman are three powerhouse investors who each have a different approach to investing.Warren Buffett is a legend who has outperformed the stock market by a landslide over his years of investing. He's a proponent of value investing, and he typically invests in large, well-established industry giants. He's joked about the average age of the companies he invests in, saying his holding company, Berkshire Hathaway, isn't big on newcomers.Cathie Wood's approach is almost diam ...